Terug

Petco Health and Wellness Company, Inc.

Datakwaliteit: 100%

WOOF

NASDAQ Consumer Cyclical Specialty Retail

€ 2,79

▼ € 0,10 (-3,46%)

Marktkapitalisatie: 793,24M

Dagbereik

€ 2,77 € 2,89

52-Weeksbereik

€ 2,24 € 4,51

Volume

2.395.113

50D / 200D Gem.

€ 2,75 / € 3,10

Vorige Slotkoers

€ 2,89

Koershistorie

Financiële Trends

Sectorvergelijking

vs Consumer Cyclical sector mediaan (610 peers)

Metriek	Aandeel	Sector Mediaan
P/E	87,5	11,1
P/B	0,7	1,4
ROE %	0,8	10,7
Net Margin %	0,2	5,1
Rev Growth 5Y %	0,7	8,1
D/E	2,5	0,8

Koersdoel Analisten

Hold

€ 3,59 +28.7%

Low: € 2,18 High: € 4,53

Forward K/W

19,7

Forward WPA

€ 0,15

WPA Groei (sch.)

+0,0%

Omzet Sch.

6 B

Winstschattingen

Periode	WPA Sch.	Omzet Sch.	Analisten
FY2030	€ 0,00 € 0,00 – € 0,00	6,2 B	2
FY2029	€ 0,30 € 0,21 – € 0,42	6,2 B	4
FY2028	€ 0,29 € 0,20 – € 0,36	6,1 B	4

Insider Trading Activity

13 transactions

Date	Insider	Type	Shares	Price	Value
Mar 4, 2026	SIMMONS SABRINA Chief Financial Officer	other	190.584	€ 2,65	€ 505.048
Mar 4, 2026	Insana Giovanni See Remarks	other	24.044	€ 2,65	€ 63.717
Mar 4, 2026	Romanko Michael See Remarks	other	130.194	€ 2,65	€ 345.014
Mar 4, 2026	May Holly Chief Human Resources Officer	other	19.758	€ 2,65	€ 52.359
Nov 18, 2025	Venezia Patrick J Chief Revenue Officer	other	55.249	€ 2,81	€ 155.250
Oct 15, 2025	May Holly Chief Human Resources Officer	other	41.811	€ 3,55	€ 148.429
Aug 1, 2025	Anderson Joel D Chief Executive Officer	grant	1.100	€ 2,48	€ 2.728
Jul 24, 2025	SIMMONS SABRINA Chief Financial Officer	other	17.574	€ 4,36	€ 76.623
Jul 24, 2025	MOHAN RAJENDRA M Director	grant	43.422	—	—
Jul 24, 2025	Yen Iris Director	grant	43.422	—	—
Jul 24, 2025	BRIGGS GARY S Director	grant	43.422	—	—
May 2, 2025	Anderson Joel D Chief Executive Officer	grant	5.000	€ 2,60	€ 13.000
Apr 10, 2025	Insana Giovanni See Remarks	other	1.682	€ 3,25	€ 5.467

Belangrijkste Punten

Revenue grew 0,66% annually over 5 years — modest growth

ROE of 0,80% is below average

Debt/Equity of 2,46 — high leverage

Generating 186,95M in free cash flow

P/E of 87,50 — premium valuation

Revenue growth is decelerating — 1Y growth trails 5Y average by 3,19%

Groei

Revenue Growth (5Y)

0,66%

Revenue (1Y)-2,53%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Kwaliteit

Return on Equity

0,80%

ROIC2,24%

Net Margin0,15%

Op. Margin2,02%

Veiligheid

Debt / Equity

2,46

Current Ratio0,90

Interest Coverage0,92

Waardering

P/E Ratio

87,50

P/B Ratio0,68

EV/EBITDA28,21

Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y)	-2,53%	Revenue Growth (3Y)	-2,38%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	0,66%	Earnings Growth (5Y)	-51,54%
Profitability
Revenue (TTM)	5,96B	Net Income (TTM)	9,07M
ROE	0,80%	ROA	0,18%
Gross Margin	38,67%	Operating Margin	2,02%
Net Margin	0,15%	Free Cash Flow (TTM)	186,95M
ROIC	2,24%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	2,46	Current Ratio	0,90
Interest Coverage	0,92	Dividend Yield	0,00%
Valuation
P/E Ratio	87,50	P/B Ratio	0,68
P/S Ratio	0,13	PEG Ratio	-0,76
EV/EBITDA	28,21	Dividend Yield	0,00%
Market Cap	793,24M	Enterprise Value	3,40B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	5,96B	6,12B	6,26B	6,04B	5,81B
Net Income	9,07M	-101,82M	-1,28B	90,80M	164,42M
EPS (Diluted)	0,03	-0,37	-4,78	0,34	0,62
Gross Profit	2,31B	2,32B	2,35B	2,43B	2,43B
Operating Income	120,43M	7,05M	-1,18B	225,56M	266,07M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	5,17B	5,19B	5,36B	6,61B	6,50B
Total Liabilities	4,01B	4,08B	4,18B	4,23B	4,24B
Shareholders' Equity	1,16B	1,11B	1,18B	2,38B	2,27B
Total Debt	2,86B	2,96B	3,04B	3,13B	3,05B
Cash & Equivalents	256,74M	165,76M	125,43M	201,90M	211,60M
Current Assets	1,02B	973,62M	951,74M	1,02B	1,07B
Current Liabilities	1,13B	1,14B	1,11B	1,02B	1,05B